Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Abruptio Placentae

17 alpha-hydroxyprogesterone caproate has been researched along with Abruptio Placentae in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, W; Biggio, J; Bukowski, R; Esplin, MS; Huang, H; Ilekis, J; Manuck, TA; Parry, S; Reddy, UM; Saade, G; Sadovsky, Y; Varner, MW; Zhang, H1

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Abruptio Placentae

ArticleYear
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:3

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abruptio Placentae; Adult; Estrogen Antagonists; Female; Gestational Age; Humans; Hydroxyprogesterones; Longitudinal Studies; Pregnancy; Pregnancy, High-Risk; Premature Birth; Prospective Studies; Recurrence; Risk Factors; Treatment Failure; Uterine Hemorrhage; Young Adult

2016